Beacon Equity Research Clients

Below you will find a list of Beacon Equity Research's clients.
Click on the client's name to view information on that specific client.

QualityStocks Partner Clients

SmallCapVoice Clients
Stock Guru Clients


Untitled Document

RepliCel Life Sciences, Inc. (REPCF)

RepliCel Life Sciences, Inc. (REPCF) is the developer of RepliCel, a natural hair cell replication technology with the potential to become the world’s first minimally invasive solution for androgenetic alopecia and general hair loss in men and women.

The RepliCel technology is based on autologous cell implantation technology that replicates a patient’s hair cells from their own healthy hair follicles. When these are introduced into areas of hair loss, it is hoped that natural hair regeneration will be initiated.

The company has been issued patents for its RepliCel technology from the European Union and Australia, with patents pending in other major international jurisdictions. The RepliCel procedure has been developed over the past decade by RepliCel’s recognized research scientists and medical experts, who are specialists in the fields of hair growth, hair biology, and dermatology.

Beacon Equity Research Blog

RepliCel Life Sciences, Inc. Message Board


The QualityStocks

Read the articles covering the biggest movers in the markets today.



Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.


The QualityStocks Daily

Go back to see our previous newsletters and find out what you might have missed.